Active substance
Nefopam
- SFDA 2
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Nefalgic | 10 mg/ml | Solution for injection · Intramuscular and intravenous use | 5 Ampoule | SAR 17.65 | Generic · Prescription | Biocodex | Valid |
| PAINSTOP 20MG-ML AMPOULE | 20 mg/ml | Solution for injection · Intravenous use | 3 Ampoule | SAR 4.05 | NCE · Prescription | MEDICAL UNION PHARMACEUTICALS CO | Invalid · Not Marketed |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Nefopam 30mg tablets | £3.73 | 90 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Nefopam 60mg tablets | £19.90 | 60 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.